Logo

Goldman Sachs

Pacific Biosciences to Raise $175M in Public Stock Offering

The company is selling 17.5 million shares of its common stock at a price of $10 per share in the offering, which is expected to close Jan. 27.

PerkinElmer Reaches Deal for $1.5B Credit Facility

The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility.

PerkinElmer Enters $500M Credit Facility

The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month.

Singular Genomics Ups IPO Target to $187M

The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation.

Sequencing Startup Singular Genomics Files for $100M IPO

The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.

Dec 2, 2020

Twist Bioscience Proposes $250M Public Offering

Jul 29, 2020

Sema4 Raises $121M in Series C Financing Round

Jul 16, 2020

Adaptive Biotechnologies to Raise $240M in Public Stock Offering

Jan 24, 2020

Adaptive Biotechnologies Prices Public Offering of Stock

Jan 21, 2020

Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering

Sep 25, 2019

Thermo Fisher Scientific Prices $5.7B Senior Notes Offering

Aug 20, 2019

10x Genomics Files for $100M IPO

Feb 27, 2019

Danaher Prices $2.76B Offering of Common, Preferred Stock

Dec 8, 2015

Goldman Sachs Upgrades Myriad, Agilent, and Thermo Fisher; Downgrades PerkinElmer, Danaher

Dec 18, 2014

Goldman Sachs Downgrades Qiagen, Bruker

Sep 2, 2014

Goldman Sachs, Leerink Initiate Coverage of T2 Biosystems

Jun 23, 2014

Goldman Sachs Reinstates Neutral Rating for Agilent

Jun 25, 2013

Goldman Sachs Upgrades Waters; Downgrades Agilent, Genomic Health

Apr 23, 2013

Quest Enters into Agreement to Buy Back $450M of Stock

Apr 11, 2013

Goldman Sachs Upgrades Quest, LabCorp, Downgrades Sigma-Aldrich

Mar 28, 2013

T2 Biosystems Raises $40M

Jan 16, 2013

Goldman Sachs Survey Finds Spending on Life Science Tools Remains Challenged by Funding, Fiscal Concerns

Dec 6, 2012

Goldman Sachs Resumes Coverage of Danaher with Neutral Rating

Nov 19, 2012

Goldman Sachs Upgrades Agilent, Bruker; Lowers Cepheid, LabCorp

Oct 11, 2012

Goldman Sachs Initiates Coverage of Genomic Health with Neutral Rating

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.